Acessibilidade / Reportar erro

Perioperative patient radiation exposure in the endoscopic removal of upper urinary tract calculi

UROLOGICAL SURVEY

STONE DISEASE

Perioperative patient radiation exposure in the endoscopic removal of upper urinary tract calculi

Jamal JE; Armenakas NA; Sosa RE; Fracchia JA

Department of Urology, Lenox Hill Hospital , New York, New York

J Endourol. 2011; 25: 1747-51

ABSTRACT BACKGROUND AND PURPOSE: The efficacy of computed tomography (CT) in detailing upper urinary tract calculi is well established. There is no established acceptable annual recommended limit for medical exposure, yet the global accepted upper limit for occupational radiation exposure is < 50 millisieverts (mSv) in any one year. We sought to appreciate the CT and fluoroscopic radiation exposure to our patients undergoing endoscopic removal of upper tract calculi during the periprocedure period.

PATIENTS AND METHODS: All patients undergoing upper urinary endoscopic stone removal between 2005 and 2009 were identified. To calculate the cumulative radiation exposure, we included all ionizing radiation imaging performed during a periprocedure period, which we defined as ≤ 90 days pre- and post-therapeutic procedure.

RESULTS: A total of 233 upper urinary tract therapeutic patient stone procedures were identified; 127 patients underwent ureteroscopy (URS) and 106 patients underwent percutaneous nephrolithotomy (PCNL). A mean 1.58 CTs were performed per patient. Ninety (38.6%) patients underwent ≥ 2 CTs in the periprocedure period, with an average number in this group of 2.49 CT/patient, resulting in approximately 49.8mSv of CT radiation exposure. Patients who were undergoing URS were significantly more likely to have multiple CTs (P = 0.003) than those undergoing PCNL. Median fluoroscopic procedure exposures were 43.3mGy for patients who were undergoing PCNL and 27.6mGy for those patients undergoing URS.

CONCLUSIONS: CT radiation exposure in the periprocedure period for patients who were undergoing endoscopic upper tract stone removal is considerable. Added to this is the procedure-related fluoroscopic radiation exposure.

Urologic surgeons should be aware of the cumulative amount of ionizing radiation received by their patients from multiple sources.

Editorial Comment

It is interesting that the authors excluded patients with a prior indwelling ureteral stenting - indeed these present a decision-making challenge as conventional imaging may have difficulty identifying residual ureteral calculi, leaving the patient and physician faced with the dilemma of stent removal or ureteroscopy. New modalities such as dual-energy CT scan imaging may prove helpful in this subset of patients, as one would anticipate that the risk of negative ureteroscopy would be higher in this group.

The average time from CT scan to ureteroscopy was 55 days in this study. It is unclear from the study what follow-up occurred during this time period. Did patients strain their urines to identify stone passage? Was any re-imaging performed on any of these patients in the interval between diagnosis and surgery? What drove the decision to proceed with ureteroscopy - did the patients have persistent colic? These questions would help delineate the significance of the findings of this study.

Only 1/3rd of patients received medical expulsive therapy - suggesting that the risk of a negative URS would be even higher than the 10% reported in this study in areas where medical expulsive therapy has become standard practice. This study highlights the need to emphasize to patients the importance of straining their urine to monitor for stone passage.

Not only does this minimize the risk for repeat imaging, but also would likely decrease the risk of unnecessary anesthesia. For patients who cannot reliably strain their urine,

reimaging with a low-dose CT pelvis should be seriously considered for those patients with distal ureteral calculi ≤ 5mm in size.

Dr. Manoj Monga

Director, Stevan B. Streem Center for

Endourology & Stone Disease

Glickman Urological & Kidney Institute

The Cleveland Clinic

Cleveland, Ohio, USA

E-mail: endourol@yahoo.com

Publication Dates

  • Publication in this collection
    16 Feb 2012
  • Date of issue
    Dec 2011
Sociedade Brasileira de Urologia Rua Bambina, 153, 22251-050 Rio de Janeiro RJ Brazil, Tel. +55 21 2539-6787, Fax: +55 21 2246-4088 - Rio de Janeiro - RJ - Brazil
E-mail: brazjurol@brazjurol.com.br